Faculty profile

Romina Mizrahi

ResearcherMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Romina Mizrahi

Researcher

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
39 publications in the last five years, latest in 2026.
Senior (last) author on 13 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

168

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Mao-B Molecular Imaging Positron Emission Tomography Schizophrenia Treatment Resistant

Latest papers

Stress and synaptic density in psychosis and clinical high risk: evidence from [18F]SynVesT-1 PET.
Translational psychiatry · 2026 · senior author
Structural covariance network topology in individuals at clinical high risk for psychosis: the ENIGMA-CHR Study.
Molecular psychiatry · 2026
Group Differences of Multiregion Glutamate Concentration in Clinical High Risk and Schizophrenia.
The European journal of neuroscience · 2026 · senior author

All 44 publications

Latest funding

Youth Cannabis Outcomes and Neurodevelopmental and Clinical Trajectories (Y-CONECT)
CIHR · 2026 · Co-investigator
$2,396,391
Targeting the Endocannabinoid System to Improve Cannabis Withdrawal in Cannabis-Tobacco Co-users
CIHR · 2023 · Co-investigator
$520,200
Investigating Endocannabinoid Activity in Brain in People with Tobacco Addiction
CIHR · 2023 · Co-investigator
$635,809

All 5 grants and awards

44 publications.

Stress and synaptic density in psychosis and clinical high risk: evidence from [18F]SynVesT-1 PET.

Blasco MB, Nisha Aji K, Ramos-Jiménez C, Chartrand D, Hsiao CH, Hopewell R, Massarweh G, Cohen J, Rusjan PM, Mizrahi R

Translational psychiatry2026Senior author

DOI: 10.1038/s41398-026-03993-9 PMID: 41986308

Structural covariance network topology in individuals at clinical high risk for psychosis: the ENIGMA-CHR Study.

Liu S, Agartz I, Allen P, Amminger GP, Andreassen OA, Bachman P, Baeza I, Baldwin H, Bartholomeusz CF, Borgwardt S, Catalano S, Chen X, Cho KIK, Choi S, Colibazzi T, Cooper RE, Corcoran CM, Cropley VL, de Haan L, de la Fuente-Sandoval C, Dolz M, Ebdrup BH, Fortea A, Fusar-Poli P, Glenthøj LB, Glenthøj BY, Haas SS, Hamilton HK, Haut KM, Hayes RA, He Y, Heekeren K, Hegelstad WTV, Hooker CI, Horton LE, Hubl D, Hwang WJ, Kaess M, Kasai K, Katagiri N, Kim M, Kindler J, Klaunig MJ, Koike S, Kristensen TD, Kwak YB, Kwon JS, Lawrie SM, Lebedeva I, Lemmers-Jansen IL, León-Ortiz P, Lin A, Loewy RL, Ma X, Mathalon DH, McGorry P, McGuire P, Michel C, Mizrahi R, Mizuno M, Møller P, Mora-Durán R, Muñoz-Samons D, Nelson B, Nemoto T, Nordentoft M, Nordholm D, Omelchenko MA, Ouyang L, Pantelis C, Pariente JC, Raghava JM, Rasser PE, Resch F, Reyes-Madrigal F, Rivera-Chávez LF, Røssberg JI, Rössler W, Salisbury DF, Sasabayashi D, Schall U, Schiffman J, Schmidt A, Smigielski L, Sørensen ME, Sugranyes G, Suzuki M, Takahashi T, Tamnes CK, Tang J, Theodoridou A, Thomopoulos SI, Tomyshev AS, Tor J, Uhlhaas PJ, Værnes TG, van Amelsvoort TA, Velakoulis D, Via E, Vinogradov S, Waltz JA, Wenneberg C, Westlye LT, Wood SJ, Yamasue H, Yuan L, Yung AR, Chee MW, Thompson PM, Hernaus D, Jalbrzikowski M, Lee J, Zhou JH, ENIGMA Clinical High Risk for Psychosis Working Group

Molecular psychiatry2026

DOI: 10.1038/s41380-025-03304-6 PMID: 41125743

Group Differences of Multiregion Glutamate Concentration in Clinical High Risk and Schizophrenia.

Man SK, Blasco MB, Alemi R, Raminfard S, Rusjan PM, Near J, Sarpal DK, Mizrahi R

The European journal of neuroscience2026Senior author

DOI: 10.1111/ejn.70626 PMID: 42432829

Local chemoarchitecture explains widespread lower cortical thickness associated with clinical high risk for psychosis.

Yang X, Agartz I, Andreassen O, Bachman P, Baeza I, Bartholomeusz C, Borgwardt S, Choi S, Colibazzi T, Cooper R, Corcoran C, de la Fuente-Sandoval C, Ebdrup B, Fortea A, Glenthøj BY, Glenthøj LB, Haas S, Hamilton H, Hayes R, He Y, Heekeren K, Ten Velden Hegelstad W, Hooker C, Kaess M, Kasai K, Katagiri N, Kim M, Kindler J, Koike S, Kristensen T, Kwon JS, Lawrie S, Lee J, Lin A, Loewy R, Mathalon D, McGorry P, Michel C, Møller P, Nemoto T, Pena M, Raghava J, Reyes-Madrigal F, Rivera-Chávez L, Rössler W, Sasabayashi D, Schall U, Schmidt A, Smigielski L, Sørensen M, Sugranyes G, Takahashi T, Tamnes C, Tang J, Theodoridou A, Tor J, Uhlhaas P, Værnes T, Via E, Vinogradov S, Waltz J, Westlye L, Wood S, Yamasue H, Yung A, Zhou J, Fusar-Poli P, Mizrahi R, Cropley V, Thompson P, van Amelsvoort T, Jalbrzikowski M, Becker B, Linden DEJ, Hernaus D, ENIGMA Clinical High Risk for Psychosis Working Group

Molecular psychiatry2026

DOI: 10.1038/s41380-026-03586-4 PMID: 41935185

Gamma auditory steady-state response and remission in antipsychotic-naïve patients at clinical high risk for psychosis: a longitudinal study

Kiang M, Lepock JR, Mizrahi R, Gerritsen CJ, Korostil M, Light GA

World Journal of Biological Psychiatry2026

DOI: 10.1080/15622975.2026.2684757

The inventory of psychotic-like anomalous self-experiences (IPASE): Stability and relationships with attenuated psychotic symptoms and remission in individuals at-risk for psychosis.

Scott I, Selloni A, Bilgrami Z, Cotter M, Sarac C, McGowan A, Krcmar M, Formica M, Gwyther K, Wannan C, Srivastava A, Cecchi GA, Mizrahi R, McGorry P, Corcoran CM, Nelson B

Schizophrenia research2025

DOI: 10.1016/j.schres.2025.05.003 PMID: 40440822

Evidence of altered monoamine oxidase B, an astroglia marker, in early psychosis and high-risk state.

Nisha Aji K, Lalang N, Ramos-Jiménez C, Rahimian R, Mechawar N, Turecki G, Chartrand D, Boileau I, Meyer JH, Rusjan PM, Mizrahi R

Molecular psychiatry2025Senior author

DOI: 10.1038/s41380-024-02816-x PMID: 39511452

PSYSCAN multi-centre study: baseline characteristics and clinical outcomes of the clinical high risk for psychosis sample.

Tognin S, Vieira S, Oliver D, Cullen AE, Kempton MJ, Fusar-Poli P, Mechelli A, Dazzan P, Merritt K, Maat A, de Haan L, Lawrie SM, van Amelsvoort T, Arango C, Nelson B, Galderisi S, Bressan R, Kwon JS, Mizrahi R, PSYSCAN Consortium, Kahn RS, McGuire P

Schizophrenia (Heidelberg, Germany)2025

DOI: 10.1038/s41537-025-00598-x PMID: 40246889

Correction: "Ask" or "Inquire": operationalizing speech formality in psychosis and its risk states using etymology.

Cotter M, McGowan A, Bilgrami Z, Sarac C, Bayer J, Spark J, Krcmar M, Formica M, Gwyther K, Hartmann J, Shuster S, Selloni A, Shah J, Herrera SN, McGorry P, Yung AR, Nelson B, Mizrahi R, Cecchi G, Heisig S, Srivastava A, Corcoran CM

NPP - digital psychiatry and neuroscience2025

DOI: 10.1038/s44277-025-00027-y PMID: 41360985

Impact of Stress on the Endocannabinoid System: A [11C]-CURB Positron Emission Tomography Study in Early Psychosis: Les effets du stress sur le système endocannabinoïde : étude par tomographie par émission de positons avec l'indicateur radioactif [11C-CURB] dans la psychose précoce.

Weidenauer A, Garani R, Campos Oller P, Belén Blasco M, Rusjan PM, Mizrahi R

Canadian journal of psychiatry. Revue canadienne de psychiatrie2025Senior author

DOI: 10.1177/07067437241300958 PMID: 39632555

Something wrong or missing on this profile? Suggest a correction

Romina Mizrahi

Research

Latest papers

Latest funding

Stress and synaptic density in psychosis and clinical high risk: evidence from [18F]SynVesT-1 PET.

Structural covariance network topology in individuals at clinical high risk for psychosis: the ENIGMA-CHR Study.

Group Differences of Multiregion Glutamate Concentration in Clinical High Risk and Schizophrenia.

Local chemoarchitecture explains widespread lower cortical thickness associated with clinical high risk for psychosis.

Gamma auditory steady-state response and remission in antipsychotic-naïve patients at clinical high risk for psychosis: a longitudinal study

The inventory of psychotic-like anomalous self-experiences (IPASE): Stability and relationships with attenuated psychotic symptoms and remission in individuals at-risk for psychosis.

Evidence of altered monoamine oxidase B, an astroglia marker, in early psychosis and high-risk state.

PSYSCAN multi-centre study: baseline characteristics and clinical outcomes of the clinical high risk for psychosis sample.

Correction: "Ask" or "Inquire": operationalizing speech formality in psychosis and its risk states using etymology.

Impact of Stress on the Endocannabinoid System: A [11C]-CURB Positron Emission Tomography Study in Early Psychosis: Les effets du stress sur le système endocannabinoïde : étude par tomographie par émission de positons avec l'indicateur radioactif [11C-CURB] dans la psychose précoce.

Youth Cannabis Outcomes and Neurodevelopmental and Clinical Trajectories (Y-CONECT)

Targeting the Endocannabinoid System to Improve Cannabis Withdrawal in Cannabis-Tobacco Co-users

Investigating Endocannabinoid Activity in Brain in People with Tobacco Addiction

Targeting the Endocannabinoid System to Improve Cannabis Withdrawal in Cannabis-Tobacco Co-users

Monoamine Oxidase B (MAO-B) in Schizophrenia and Cannabis use

Frequent collaborators

Michael Kiang

Pablo Rusjan

Romina Mizrahi

Sophia Frangou

Michele Korostil

Isabelle Boileau

Jai Shah

Jai Shah

Martin Lepage

Jamie Near

Jeremy Watts

Gustavo Turecki

Naguib Mechawar

Khunsa Faiz

Martin Lepage

Neil Vasdev

Nathan Kolla

Mallar Chakravarty